• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴雷特食管中的食管贲门失弛缓症与腺癌:两例报告并文献复习

Esophageal achalasia and adenocarcinoma in Barrett's esophagus: a report of two cases and a review of the literature.

作者信息

Ellis F H, Gibb S P, Balogh K, Schwaber J R

机构信息

Department of Anatomic Pathology, Deaconess Hospital, Boston, MA 02115, USA.

出版信息

Dis Esophagus. 1997 Jan;10(1):55-60. doi: 10.1093/dote/10.1.55.

DOI:10.1093/dote/10.1.55
PMID:9079276
Abstract

Two cases of a rare combination of conditions, achalasia and adenocarcinoma in Barrett's esophagus are reported. Cancer developed 26 years after the onset of gastroesophageal reflux in one and 30 years after esophagomyotomy in the other. Twenty-one cases of Barrett's esophagus and achalasia have now been reported; adenocarcinoma developed in six patients. Only one has survived more than five years after treatment. Long-term surveillance of patients with achalasia is recommended.

摘要

报告了两例贲门失弛缓症与巴雷特食管腺癌这一罕见病症组合的病例。其中一例在胃食管反流发病26年后发生癌变,另一例在食管肌层切开术后30年发生癌变。目前已报告21例巴雷特食管合并贲门失弛缓症的病例;6例患者发生了腺癌。治疗后只有1例存活超过5年。建议对贲门失弛缓症患者进行长期监测。

相似文献

1
Esophageal achalasia and adenocarcinoma in Barrett's esophagus: a report of two cases and a review of the literature.巴雷特食管中的食管贲门失弛缓症与腺癌:两例报告并文献复习
Dis Esophagus. 1997 Jan;10(1):55-60. doi: 10.1093/dote/10.1.55.
2
Esophageal adenocarcinoma following Heller myotomy for achalasia.贲门失弛缓症行Heller肌切开术后发生的食管腺癌。
Endoscopy. 1987 Mar;19(2):76-8. doi: 10.1055/s-2007-1018241.
3
Barrett's esophagus and achalasia.巴雷特食管和贲门失弛缓症。
J Clin Gastroenterol. 2002 Apr;34(4):439-43. doi: 10.1097/00004836-200204000-00011.
4
Barrett's esophagus complicating achalasia after esophagomyotomy. A clinical, radiologic, and pathologic study of 70 patients with achalasia and related motor disorders.食管肌层切开术后并发贲门失弛缓症的巴雷特食管。70例贲门失弛缓症及相关运动障碍患者的临床、放射学及病理学研究。
J Clin Gastroenterol. 1987 Apr;9(2):232-7.
5
Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux.巴雷特食管:在有胃食管反流症状的患者中的患病率及其与腺癌的关联。
Am J Surg. 1985 Jan;149(1):187-93. doi: 10.1016/s0002-9610(85)80031-3.
6
Hepatoid adenocarcinoma in Barrett's esophagus associated with achalasia: first case report.巴雷特食管伴贲门失弛缓症中的肝样腺癌:首例病例报告。
Pathol Int. 2002 Feb;52(2):141-6. doi: 10.1046/j.1440-1827.2002.01328.x.
7
Esophageal adenocarcinoma in a patient with surgically treated achalasia.一名接受过手术治疗的贲门失弛缓症患者发生食管腺癌。
Dig Dis Sci. 1990 Dec;35(12):1549-52. doi: 10.1007/BF01540574.
8
Barrett's esophagus in a patient with achalasia.贲门失弛缓症患者的巴雷特食管。
Am J Gastroenterol. 1985 May;80(5):330-3.
9
Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia.巴雷特食管和食管腺癌在贲门失弛缓症治疗后很常见。
Dig Dis Sci. 2013 Jan;58(1):244-52. doi: 10.1007/s10620-012-2157-9. Epub 2012 Nov 22.
10
Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.食管裂孔疝大小、巴雷特食管长度以及胃酸反流的严重程度均为食管腺癌的危险因素。
Am J Gastroenterol. 2002 Aug;97(8):1930-6. doi: 10.1111/j.1572-0241.2002.05902.x.

引用本文的文献

1
Massive esophageal bleeding in long-standing achalasia complicated by esophageal carcinoma and aspirin-induced stasis ulcer: Case report.长期贲门失弛缓症并发食管癌及阿司匹林所致淤血性溃疡导致的大量食管出血:病例报告
Medicine (Baltimore). 2019 Jul;98(30):e16519. doi: 10.1097/MD.0000000000016519.
2
Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia.巴雷特食管和食管腺癌在贲门失弛缓症治疗后很常见。
Dig Dis Sci. 2013 Jan;58(1):244-52. doi: 10.1007/s10620-012-2157-9. Epub 2012 Nov 22.
3
Achalasia combined with esophageal cancer treated by concurrent chemoradiation therapy.
贲门失弛缓症合并食管癌同期放化疗治疗。
Gut Liver. 2009 Dec;3(4):329-33. doi: 10.5009/gnl.2009.3.4.329. Epub 2009 Dec 31.